DE0005313704
© EQS Newswire
11.12.2025
AFX
LISTED
XETR
Carl Zeiss Meditec closes fiscal year 2024/25 with solid growth in revenue and slight increase in EBITA
News Preview
Carl Zeiss Meditec closes fiscal year 2024/25 with solid growth in revenue and slight increase in EBITA[1]
Growth in both equipment and consumables sales, along with stronger order intake and higher order backlogs at year-end
JENA, 11 December 2025
Carl Zeiss Meditec achieved revenue of EUR 2,228 million in fiscal year 2024/25 (prior year:......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.12.2025
AFX
LISTED
XETR
Carl Zeiss Meditec schließt das Geschäftsjahr 2024/25 mit solidem Umsatzwachstum und einem leichten Anstieg des EBITA ab
News Preview
Carl Zeiss Meditec schließt das Geschäftsjahr 2024/25 mit solidem Umsatzwachstum und einem leichten Anstieg des EBITA[1] ab
Umsatzwachstum bei Geräten und Verbrauchsmaterialien sowie stärkere Auftragseingänge und Auftragsbestände zum Jahresende
JENA, 11. Dezember 2025
Carl Zeiss Meditec erreichte im Geschäftsjahr 2024/25 einen Umsatz v......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.12.2025
AFX
LISTED
XETR
Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026
News Preview
Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 –
interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch
Jena, 8 December 2025
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) ......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© EQS Newswire
08.12.2025
AFX
LISTED
XETR
Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme des Vorstandsvorsitzes durch Andreas Pecher zum 01.01.2026
News Preview
Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme des Vorstandsvorsitzes durch Andreas Pecher zum 01.01.2026 – interimistische Übernahme des Aufsichtsratsvorsitzes durch Peter Kameritsch
Jena, 08. Dezember 2025
Der Aufsichtsrat der Carl Zeiss Meditec AG (ISIN: DE0005313704) und Maximilia......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
AFX
LISTED
XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
AFX
LISTED
XETR
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
News Preview
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark:
EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powered CIRRUS® PathFinder™ clinical support tool now CE mark approved; presenting a fully integrated diagnostic and SLT therapeutic solution for managing...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
AFX
LISTED
XETR
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
News Preview
At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care:
IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.08.2025
AFX
LISTED
XETR
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
News Preview
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
Significant recovery and further expansion of order entry compared to prior year
JENA, 7 August 2025
Carl Zeiss Meditec generated revenue of €1,600.1m in the first nine months of fiscal year 2024/25 (prior year: €1,486.5m), including the DORC consolidation, c......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.08.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt Umsatz- und Ergebniswachstum nach neun Monaten 2024/25
News Preview
Carl Zeiss Meditec erzielt Umsatz- und Ergebniswachstum nach neun Monaten 2024/25
Auftragseingang gegenüber Vorjahr weiter deutlich erholt und ausgebaut
JENA, 7. August 2025
Carl Zeiss Meditec erzielte in den ersten neun Monaten des Geschäftsjahres 2024/25 inklusive der DORC-Konsolidierung einen Umsatz von rund 1.600,1 Millionen Euro
(Vj. ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
13.05.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt Umsatzwachstum und stabilen operativen Gewinn im ersten Halbjahr 2024/25
News Preview
Carl Zeiss Meditec erzielt Umsatzwachstum und stabilen operativen Gewinn im ersten Halbjahr 2024/25
Auftragseingang gegenüber Vorjahr weiter erholt
JENA, 13. Mai 2025
Carl Zeiss Meditec erzielte in den ersten sechs Monaten des Geschäftsjahres 2024/25 inklusive der DORC-Konsolidierung einen Umsatz von rund 1.050,5 Millionen Euro (Vj. 947,2 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
13.05.2025
AFX
LISTED
XETR
Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
News Preview
Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
Further recovery in order entry compared to prior year
JENA, 13 May 2025
Carl Zeiss Meditec generated revenue of €1,050.5m in the first half of fiscal year 2024/25 (prior year: €947.2m), including the DORC consolidation, corresponding ......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Change of President and CEO at Carl Zeiss Meditec AG
News Preview
Change of President and CEO at Carl Zeiss Meditec AG
The President and CEO, Dr. Markus Weber, will step down from the Management Board, of his own accord and on the best of terms, on 31 May 2025.
Starting 1 June 2025, the new President and CEO will be Maximilian Foerst, who is currently Head of ZEISS Greater China.
Jena, Germany | 7 May 2025 | C......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Wechsel an Vorstandsspitze der Carl Zeiss Meditec AG
News Preview
Wechsel an Vorstandsspitze der Carl Zeiss Meditec AG
Der Vorstandsvorsitzende Dr. Markus Weber scheidet auf eigenen Wunsch und im besten Einvernehmen mit Ablauf des 31.05.2025 aus dem Vorstand aus.
Neuer Vorstandsvorsitzender wird Maximilian Foerst mit Wirkung zum 01.06.2025, derzeit Head of ZEISS Greater China.
Jena, Deutschlan......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
News Preview
Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
Jena, 7. Mai 2025
Der Aufsichtsrat der Carl Zeiss Meditec AG (ISIN: DE0005313704) hat in seiner heutigen Sitzung eine Veränderung im Vorstand des Unternehmens beschlossen. Dr. Markus Weber, der seit 1. Januar 2022 Vorstandsvorsitzender der Gesellschaft ist, wird sein Amt zum 31. Mai 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.05.2025
AFX
LISTED
XETR
Change of President and CEO at Carl Zeiss Meditec AG
News Preview
Change of President and CEO at Carl Zeiss Meditec AG
Jena, May 7, 2025
The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maxi......
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
AFX
LISTED
XETR
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
News Preview
Showcasing the future of ophthalmic research at ARVO 2025:
ZEISS Research Data Platform launch - a cloud-based, AI-driven technology solution designed to accelerate discoveries, integrating research and clinical data, and simplifying research workflows.ZEISS's collaboration with Boehringer Ingelheim - championing data-driven, personalized care th...
Themefolio
Profiler
Peergroup
© PR Newswire
17.04.2025
AFX
LISTED
XETR
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
News Preview
Showcasing at ASCRS 2025:
More than 2 million cases planned with ZEISS VERACITY Surgery Planner: Growing use of one of the leading digital planning solutions for cataract surgery in the U.S. is a testament to the increased adoption of the ZEISS Cataract Workflow digital solutions by surgeons.ZEISS MEL 90 broadens refractive treatment portfolio: U...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.04.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt deutliche Gewinnsteigerung im zweiten Quartal 2024/25
News Preview
Carl Zeiss Meditec erzielt deutliche Gewinnsteigerung im zweiten Quartal 2024/25
Jena, 15. April 2025
Im zweiten Quartal des Geschäftsjahres 2024/25 zum 31. März 2025 erzielte die Carl Zeiss Meditec AG (ISIN: DE0005313704) auf Basis vorläufiger Daten einen Umsatz von rund 560 Millionen (Mio.) EUR (Vorjahr 472,1 Mio. EUR) – ein Anstieg von......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.04.2025
AFX
LISTED
XETR
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
News Preview
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
Jena, April 15, 2025
In the second quarter of fiscal year 2024/25 ending March 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of around EUR 560 million (previous year: EUR 472.1 million), based on preliminary data, an increase of around 19%.......
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
AFX
LISTED
XETR
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
News Preview
JENA, Germany, March 27, 2025 /CNW/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) approval in China, marking a significant milestone in the product's global journey....
Themefolio
Profiler
Peergroup
© EQS Newswire
27.02.2025
AFX
LISTED
XETR
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
News Preview
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements.
JENA,(Germany), SHANGHAI, (China), | 27 February 2025 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced to......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
AFX
LISTED
XETR
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
News Preview
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
Significant recovery in order entry and order backlog
JENA, 12 February 2025
Carl Zeiss Meditec generated revenue of €490.5m in the first three months of fiscal year 2024/25 (prior year: €475.0m), corresponding to growth of +3.2% (adjusted for currency effec......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.02.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25
News Preview
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2024/25
Auftragseingang und Auftragsbestand deutlich erholt
JENA, 12. Februar 2025
Carl Zeiss Meditec erzielte im ersten Quartal des Geschäftsjahres 2024/25 aufgrund der DORC-Akquisition einen Umsatz von rund 490,5 Millionen Euro (Vj. 475,0 Millionen Euro), ein Wachstum v......
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2025
AFX
LISTED
XETR
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
News Preview
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.
DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /CNW/ -- ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administratio...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.12.2024
AFX
LISTED
XETR
Carl Zeiss Meditec schließt das Geschäftsjahr 2023/24 mit leicht rückläufigem Umsatz ab – Prognose für bereinigtes EBIT erreicht
News Preview
Carl Zeiss Meditec schließt das Geschäftsjahr 2023/24 mit leicht rückläufigem Umsatz ab – Prognose für bereinigtes EBIT erreicht
Restriktives Investitionsklima und schwache Verbraucherstimmung belasten Umsatz- und Ertragsentwicklung
JENA, 11. Dezember 2024
Carl Zeiss Meditec erreichte im Geschäftsjahr 2023/24 einen Umsatz von rund 2.06......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.12.2024
AFX
LISTED
XETR
Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
News Preview
Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
Restrictive investment climate and low consumer confidence impact revenue and earnings performance
JENA, 11 December 2024
Carl Zeiss Meditec generated revenue of €2,066.1m in fiscal year 2023/24 (prior year: €2,089.3m), corres......
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
AFX
LISTED
XETR
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions
News Preview
Showcasing at AAO 2024:
ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations.ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMILE and ZEISS SMILE pro.ZEISS marked its 25th year of leadersh...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2024
AFX
LISTED
XETR
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.
News Preview
The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space, minimizing risk to surrounding eye structures and increasing operating room efficiency.
DUBLIN, Calif. and JENA, Germany, Sept. 26, 2024 /CNW/ -- ZEISS Medical Technology today announced the broad U.S. dist...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
AFX
LISTED
XETR
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
News Preview
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:
THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.08.2024
AFX
LISTED
XETR
Carl Zeiss Meditec schließt die ersten neun Monate 2023/24 mit leicht rückläufigem Umsatz ab
News Preview
Carl Zeiss Meditec schließt die ersten neun Monate 2023/24 mit leicht rückläufigem Umsatz ab
Restriktives Investitionsklima und niedrige Verbraucherstimmung belasten Umsatz- und Ertragsentwicklung
JENA, 6. August 2024
Carl Zeiss Meditec erreichte in den ersten neun Monaten des Geschäftsjahres 2023/24 einen Umsatz von rund 1.486,5 Millionen......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.08.2024
AFX
LISTED
XETR
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
News Preview
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Restrictive investment climate and low consumer confidence impact revenue and earnings performance
JENA, 6 August 2024
Carl Zeiss Meditec generated revenue of around €1,486.5m in the first nine months of fiscal year 2023/24 (prior year: €1,509.6m) corresp......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
AFX
LISTED
XETR
Prognose für Geschäftsjahr 2023/24 für Umsatz und EBIT aufgrund langsamer als erwarteter Erholung des Gerätegeschäfts reduziert
News Preview
Prognose für Geschäftsjahr 2023/24 für Umsatz und EBIT aufgrund langsamer als erwarteter Erholung des Gerätegeschäfts reduziert
Jena, 17. Juni 2024
In den ersten 8 Monaten des Geschäftsjahres 2023/24 zum 31. Mai 2024 erzielte die Carl Zeiss Meditec AG (ISIN: DE0005313704) ohne den Beitrag aus dem Erwerb von Dutch Ophthalmic Research Cent......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
AFX
LISTED
XETR
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
News Preview
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Jena, June 17, 2024
In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2024
AFX
LISTED
XETR
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
News Preview
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Jena, June 17, 2024
In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
AFX
LISTED
XETR
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
News Preview
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed
JENA, 8 May 2024
Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
AFX
LISTED
XETR
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
News Preview
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed
JENA, 8 May 2024
Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
AFX
LISTED
XETR
Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab
News Preview
Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab
Planmäßiger Vorratsabbau von chirurgischen Verbrauchsmaterialien im chinesischen Vertriebskanal erfolgreich beendet
JENA, 8. Mai 2024
Carl Zeiss Meditec erreichte in den ersten sechs Monaten des Geschäftsjahres 2023/24 einen Umsatz von run......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.05.2024
AFX
LISTED
XETR
Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab
News Preview
Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab
Planmäßiger Vorratsabbau von chirurgischen Verbrauchsmaterialien im chinesischen Vertriebskanal erfolgreich beendet
JENA, 8. Mai 2024
Carl Zeiss Meditec erreichte in den ersten sechs Monaten des Geschäftsjahres 2023/24 einen Umsatz von run......
Themefolio
Profiler
Peergroup
© EQS Newswire
09.02.2024
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2023/24
News Preview
Carl Zeiss Meditec erzielt leichtes Umsatzwachstum im ersten Quartal 2023/24
Gewinnrückgang aufgrund des erwartungsgemäß schwächeren Produktmix
JENA, 9. Februar 2024
Carl Zeiss Meditec erzielte im ersten Quartal des Geschäftsjahres 2023/24 einen Umsatz von rund 475,0 Millionen Euro (Vj. 470,......
Themefolio
Profiler
Peergroup
© EQS Newswire
09.02.2024
AFX
LISTED
XETR
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
News Preview
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Decline in profit due to expected weaker product mix
JENA, 9 February 2024
Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%)......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.01.2024
AFX
LISTED
XETR
Carl Zeiss Meditec AG beschließt Aktienrückkaufprogramm mit einem Volumen von bis zu 150 Millionen Euro
News Preview
Carl Zeiss Meditec AG beschließt Aktienrückkaufprogramm mit einem Volumen von bis zu 150 Millionen Euro
Jena, 29. Januar 2024
Der Vorstand der Carl Zeiss Meditec AG (ISIN: DE0005313704) hat mit Zustimmung des Aufsichtsrats soeben beschlossen, ein Aktienrückkaufprogramm aufzulegen. Im Rahmen dieses Aktienrückkaufprogramms sollen für bis......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.01.2024
AFX
LISTED
XETR
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
News Preview
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jena, 29 January 2024
The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.01.2024
AFX
LISTED
XETR
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
News Preview
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.
DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced today tha......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.01.2024
AFX
LISTED
XETR
VISUMAX 800 mit SMILE pro Software von ZEISS erhält FDA-Zulassung in den USA
News Preview
VISUMAX 800 mit SMILE pro Software von ZEISS erhält FDA-Zulassung in den USA
Die neueste Generation des ZEISS Femtosekundenlasers bietet der Refraktivchirurgie schnellere Behandlungsmöglichkeiten, größere Flexibilität und einen verbesserten klinischen Arbeitsablauf.
Jena / Deutschland | Dublin / USA | 11. Januar 2024
Heute gibt die Medizi......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
